TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1902159

Group type: EXPERIMENTAL
Intervention: Active nitroglycerin patches (mean necessary effective patch dose: 125 sq cm, range 60 to 220 sq cm)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo patches
Number of subjects: 8
Study: 7120957

Group type: EXPERIMENTAL
Intervention: 1-sec interval between responses
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 10-sec interval between responses
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Sentence completion and picture naming tasks
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Increased semantic difficulty
Number of subjects: 31
Study: 31277151

Group type: EXPERIMENTAL
Intervention: Stand Up and Move More intervention (n=40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Wait-list control (n=40)
Number of subjects: 80
Study: 27753201

Group type: EXPERIMENTAL
Intervention: Liraglutide (1.8 mg/d) for 12 weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 32
Study: 27178766

Group type: EXPERIMENTAL
Intervention: Protein supplementation
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: In-home rehabilitation plus placebo supplementation
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: In-home rehabilitation plus protein supplementation
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Single testosterone injection
Number of subjects: 100

Group type: COMPARATOR
Intervention: Isocaloric placebo supplementation
Number of subjects: 100
Study: 24379118

Group type: EXPERIMENTAL
Intervention: Subcuticular running monocryl suture sealed with 2-octyl cyanoacrylate (OCA)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Metallic staples
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Subcuticular running monocryl suture sealed with OCA
Number of subjects: 103
Study: 22147468

Group type: EXPERIMENTAL
Intervention: Inoculated silage (IN) with mixed bacterial culture (1.0 × 10(11) cfu/g Lactobacillus buchneri LN4017, 2.0 × 10(10) cfu/g Lactobacillus plantarum LP7109, 1.0 × 10(10) cfu/g Lactobacillus casei LC3200)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inoculated silage (IN)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control silage (UN)
Number of subjects: 0
Study: 19682374

Group type: EXPERIMENTAL
Intervention: clinic + outreach
Number of subjects: 16

Group type: COMPARATOR
Intervention: clinic only
Number of subjects: 16
Study: 17292954

Group type: EXPERIMENTAL
Intervention: Nabumetone (2 g or 1 g for 11 patients)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Meloxicam (15 mg)
Number of subjects: 70
Study: 14749635

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (400 microg)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Vaginal misoprostol (400 microg)
Number of subjects: 74
Study: 9621139

Group type: EXPERIMENTAL
Intervention: pH5 Eucerin aftersun lotion with 10% hamamelis distillate
Number of subjects: 30

Group type: COMPARATOR
Intervention: Other lotions (vehicle and prior aftersun formulation)
Number of subjects: 30
Study: 7939074

Group type: EXPERIMENTAL
Intervention: QD regimen (amlodipine)
Number of subjects: 113

Group type: COMPARATOR
Intervention: BID regimen (nifedipine SR)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 113
Study: 3280325

Group type: EXPERIMENTAL
Intervention: Norfloxacin
Number of subjects: 139

Group type: COMPARATOR
Intervention: Sulfamethoxazole plus trimethoprim (SXT)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Oral vancomycin plus colistin (V/C)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 139

Group type: COMPARATOR
Intervention: V/C
Number of subjects: 139
Study: 31845383

Group type: EXPERIMENTAL
Intervention: SPOT-Fold method
Number of subjects: 301
Study: 31965768

Group type: EXPERIMENTAL
Intervention: Training group (bicycling on lower limb ergometer 4 days/week for 8 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Training group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 29143667

Group type: EXPERIMENTAL
Intervention: microdose rHuEpo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: adaptive model
Number of subjects: 39
Study: 25826606

Group type: EXPERIMENTAL
Intervention: Empathy appeal antismoking messages
Number of subjects: 189

Group type: COMPARATOR
Intervention: Fear appeal messages
Number of subjects: 189
Study: 23336474

Group type: EXPERIMENTAL
Intervention: Targeted case-finding approach
Number of subjects: 1634

Group type: COMPARATOR
Intervention: Opportunistic case-finding approach
Number of subjects: 1634
Study: 21228725

Group type: EXPERIMENTAL
Intervention: Constant load exercise (60% peak oxygen uptake)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Intermittent exercise (80% and 40% peak oxygen uptake)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Both exercise sessions (constant load and intermittent)
Number of subjects: 23
Study: 19624590

Group type: EXPERIMENTAL
Intervention: CVVH during cardiopulmonary bypass
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard cardiopulmonary bypass
Number of subjects: 40
Study: 17164830

Group type: EXPERIMENTAL
Intervention: Barley-containing meals
Number of subjects: 14

Group type: COMPARATOR
Intervention: Wheat-containing meals
Number of subjects: 14
Study: 15281530

Group type: EXPERIMENTAL
Intervention: Arginine vasopressin (AVP) infusion (4 U/h)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Norepinephrine (NE) infusion alone
Number of subjects: 42
Study: 11951146

Group type: EXPERIMENTAL
Intervention: Delta(9)-THC (5.0, 7.5 or 10.0 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Delta(9)-THC
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9526750

Group type: EXPERIMENTAL
Intervention: Rehabilitation governed by Functional Independence Measure (FIM)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional methods of rehabilitation
Number of subjects: 34
Study: 7925223

Group type: EXPERIMENTAL
Intervention: Endurance exercise (E)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Endurance exercise with energy restriction (D+E)
Number of subjects: 10
Study: 2477096

Group type: EXPERIMENTAL
Intervention: 7.5% NaCl/Dextran 70 solution
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 787449

Group type: EXPERIMENTAL
Intervention: Tobramycin
Number of subjects: 80

Group type: COMPARATOR
Intervention: Gentamicin
Number of subjects: 80
Study: 30617461

Group type: EXPERIMENTAL
Intervention: l-bupivacaine (12.5 mg h−1) continuous wound infusion for 48 hours via a pre-sternal multiperforated catheter
Number of subjects: 1493

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 1493

Group type: EXPERIMENTAL
Intervention: l-bupivacaine (12.5 mg h−1) continuous wound infusion for 48 hours
Number of subjects: 1493
Study: 27832977

Group type: EXPERIMENTAL
Intervention: CHARM score
Number of subjects: 7011
Study: 26003664

Group type: EXPERIMENTAL
Intervention: Depression self-care toolkit with lay telephone coaching
Number of subjects: 223

Group type: COMPARATOR
Intervention: Depression self-care toolkit without lay telephone coaching (control)
Number of subjects: 223
Study: 23433430

Group type: EXPERIMENTAL
Intervention: Dairy snacks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 40
Study: 21250913

Group type: EXPERIMENTAL
Intervention: rHuEPOα therapy (300 IU/kg/dose, 3 times/week, subcutaneously)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no rHuEPOα therapy)
Number of subjects: 30
Study: 19318900

Group type: EXPERIMENTAL
Intervention: Medicare Coordinated Care Demonstration intervention
Number of subjects: 999

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 999
Study: 17365992

Group type: EXPERIMENTAL
Intervention: Rifampicin
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ketoconazole
Number of subjects: 32
Study: 15125124

Group type: EXPERIMENTAL
Intervention: Computer-assisted knee arthroplasty
Number of subjects: 70
Study: 11238150

Group type: EXPERIMENTAL
Intervention: Relenza Diskhaler
Number of subjects: 73

Group type: COMPARATOR
Intervention: Turbohaler
Number of subjects: 73
Study: 9595999

Group type: EXPERIMENTAL
Intervention: Femoral injection of echo contrast medium
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Femoral injection of echo contrast medium plus Valsalva maneuver
Number of subjects: 44

Group type: COMPARATOR
Intervention: Ante cubital injection of echo contrast medium
Number of subjects: 44

Group type: COMPARATOR
Intervention: Ante cubital injection of echo contrast medium plus Valsalva maneuver
Number of subjects: 44
Study: 8054291

Group type: EXPERIMENTAL
Intervention: Oral midazolam 7.5 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 2536410

Group type: EXPERIMENTAL
Intervention: Salt and peroxide oral hygiene regimen
Number of subjects: 171

Group type: COMPARATOR
Intervention: Conventional oral hygiene methods
Number of subjects: 171
Study: 803730

Group type: EXPERIMENTAL
Intervention: Bactrim for three months
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo for three months
Number of subjects: 96
Study: 30719632

Group type: EXPERIMENTAL
Intervention: CT-P10
Number of subjects: 372

Group type: COMPARATOR
Intervention: Combined rituximab (US-RTX and EU-RTX)
Number of subjects: 372

Group type: COMPARATOR
Intervention: US-RTX
Number of subjects: 372

Group type: COMPARATOR
Intervention: EU-RTX
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: CT-P10 and rituximab
Number of subjects: 372
Study: 27436543

Group type: EXPERIMENTAL
Intervention: 6.5-mm hydrophilic implants placed with osteotome sinus floor elevation (OSFE)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard implants placed with lateral sinus floor elevation
Number of subjects: 38

Group type: COMPARATOR
Intervention: Long implant group
Number of subjects: 38
Study: 25376753

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Wait list control
Number of subjects: 109
Study: 23736112

Group type: EXPERIMENTAL
Intervention: Amlodipine 5mg
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Candesartan 8mg
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Indapamide sustained-release 1.5mg
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study: 21487155

Group type: EXPERIMENTAL
Intervention: 1 min rest interval (1RI)
Number of subjects: 28

Group type: COMPARATOR
Intervention: 3 min rest interval (3RI)
Number of subjects: 28
Study: 19883185

Group type: EXPERIMENTAL
Intervention: Total tonsillectomy (TE)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Tonsillotomy (TT)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 67
Study: 16548305

Group type: EXPERIMENTAL
Intervention: Self-etching primer (3M Transbond Plus) combined with Transbond XT paste
Number of subjects: 62

Group type: COMPARATOR
Intervention: Conventional acid-etching (Orthosolo primer and Enlight adhesive paste)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Molar tube bonding with self-etching primer
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Mandibular tubes
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Right-sided tubes
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Second molar tubes
Number of subjects: 62
Study: 15719741

Group type: EXPERIMENTAL
Intervention: Weitai capsule (WTC), 4 capsules, 3 times a day for 3 months
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no WTC)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 62
Study: 12884459

Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quinupristin/dalfopristin
Number of subjects: 0
Study: 10510988

Group type: EXPERIMENTAL
Intervention: IV unfractionated heparin (UFH) - loading dose: 5000 U IV; initial infusion, 1250‐1280 U/h
Number of subjects: 961
Study: 7718899

Group type: EXPERIMENTAL
Intervention: CY‐TBI (120 mg/kg of cyclophosphamide followed by total body irradiation)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: BU‐CY (16 mg/kg of busulfan followed by 120 mg/kg of cyclophosphamide)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: CY‐TBI
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: BU‐CY
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: SDTBI
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: FTBI
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: MoAb (anti‐interleukin‐2 receptor monoclonal antibody)
Number of subjects: 120

Group type: COMPARATOR
Intervention: No MoAb
Number of subjects: 120
Study: 2391395

Group type: EXPERIMENTAL
Intervention: SCH 39304 alone
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: SCH 39304 with antacid
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: SCH 39304 with cimetidine
Number of subjects: 9
Study: 6792073

Group type: EXPERIMENTAL
Intervention: Parenteral diet (1.5 g amino acid . kg‐1 . d‐1 and 7.6 g carbohydrate kg . d‐1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Increased carbohydrate infusion (1.5 g amino acids . kg‐1 . d‐1 and 12 g carbohydrate . kg‐1 . d‐1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Two-fold amino acid intake (3.0 g . kg‐1 . d‐1 and 7.6 g carbohydrates . kg‐1 . d‐1)
Number of subjects: 30
Study: 31663981

Group type: EXPERIMENTAL
Intervention: 10-μg estradiol (E2) softgel vaginal insert
Number of subjects: 50

Group type: COMPARATOR
Intervention: 25-μg estradiol (E2) softgel vaginal insert
Number of subjects: 50

Group type: COMPARATOR
Intervention: Reference product (control)
Number of subjects: 50
Study: 29741558

Group type: EXPERIMENTAL
Intervention: High-egg diet (≥12 eggs/wk)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Low-egg diet (<2 eggs/wk)
Number of subjects: 128
Study: 26170395

Group type: EXPERIMENTAL
Intervention: 4 repeated doses of albendazole
Number of subjects: 2436

Group type: COMPARATOR
Intervention: Single dose of albendazole
Number of subjects: 2436
Study: 25129877

Group type: EXPERIMENTAL
Intervention: <1 drink/day
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: 1 to 2 drinks/day
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: 3+ drinks/day
Number of subjects: 449

Group type: COMPARATOR
Intervention: none
Number of subjects: 449
Study: 23395006

Group type: EXPERIMENTAL
Intervention: Guide to Decide (GtD)
Number of subjects: 1012

Group type: COMPARATOR
Intervention: Time 1 control
Number of subjects: 1012

Group type: COMPARATOR
Intervention: 3‐month control
Number of subjects: 1012
Study: 20801542

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 52
Study: 18361808

Group type: EXPERIMENTAL
Intervention: Double balloon kyphoplasty
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Single balloon kyphoplasty
Number of subjects: 51
Study: 16289984

Group type: EXPERIMENTAL
Intervention: Positively charged oil/water nanoemulsions containing ceramide 3B and SC lipids (PNSC)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Physiogel cream (control)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Negatively charged o/w nanoemulsion and SC lipids (NNSC)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Positively charged oil/water nanoemulsions (PN)
Number of subjects: 42
Study: 15127991

Group type: EXPERIMENTAL
Intervention: Tapered Brånemark System Mark IV fixture (97 implants)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Brånemark Standard or Mark II implants (92 implants)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups (Mark IV and control implants)
Number of subjects: 40
Study: 11038030

Group type: EXPERIMENTAL
Intervention: Once-weekly schedule of 5-fluorouracil and L-folinic acid
Number of subjects: 4927

Group type: COMPARATOR
Intervention: Four-weekly schedule of 5-fluorouracil and L-folinic acid
Number of subjects: 4927
Study: 8815692

Group type: EXPERIMENTAL
Intervention: Delavirdine mesylate (DLV)
Number of subjects: 1000
Study: 1356646

Group type: EXPERIMENTAL
Intervention: Atracurium (ATR) - loading dose 0.25 mg.kg‐1, infusion at 5.0 micrograms.kg‐1.min‐1
Number of subjects: 50

Group type: COMPARATOR
Intervention: Vecuronium (VEC) - loading dose 0.05 mg.kg‐1, infusion at 1.0 microgram.kg‐1.min‐1
Number of subjects: 50
Study: 3910768

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg administered 1 hour before a standardized breakfast
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg administered together with a standardized breakfast
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo administered for 2 weeks prior to captopril
Number of subjects: 18
Study: 30486575

Group type: EXPERIMENTAL
Intervention: 30 s cryoablation (Group C)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 2-minute cryoablation (Group D)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Tracheotomy alone (Group A)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Intra-tracheal brush rubbing (Group B)
Number of subjects: 32
Study: 27537754

Group type: EXPERIMENTAL
Intervention: 1 g IV paracetamol
Number of subjects: 21

Group type: COMPARATOR
Intervention: 1 g oral paracetamol
Number of subjects: 21

Group type: COMPARATOR
Intervention: 1.5 g oral paracetamol
Number of subjects: 21
Study: 25434143

Group type: EXPERIMENTAL
Intervention: Health education path intervention
Number of subjects: 60
Study: 22854666

Group type: EXPERIMENTAL
Intervention: 10 μg hepatitis B vaccine
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: 20 μg hepatitis B vaccine
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Booster dose at year 23
Number of subjects: 81

Group type: COMPARATOR
Intervention: Overall study findings
Number of subjects: 81
Study: 20172654

Group type: EXPERIMENTAL
Intervention: 25mg of amitriptyline
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo pill
Number of subjects: 118
Study: 18401269

Group type: EXPERIMENTAL
Intervention: Microdebrider-assisted inferior turbinoplasty with lateralization (MAITL)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Submucosal resection (SR)
Number of subjects: 160
Study: 16036433

Group type: EXPERIMENTAL
Intervention: Intrathecal BDNF (25 or 150 microg/day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intrathecal BDNF
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 12622499

Group type: EXPERIMENTAL
Intervention: Tramadol 20 mg intravenous bolus via patient-controlled analgesia device
Number of subjects: 44

Group type: COMPARATOR
Intervention: Morphine 2 mg intravenous bolus via patient-controlled analgesia device
Number of subjects: 44
Study: 10676043

Group type: EXPERIMENTAL
Intervention: Raloxifene, specific dosage and duration not available
Number of subjects: 0
Study: 7547044

Group type: EXPERIMENTAL
Intervention: Peritonsillar infiltration with tenoxicam 5 mg in 8 ml of normal saline (4 ml per tonsil)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal saline only (placebo)
Number of subjects: 50
Study: 1778925

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF, 9 mg/kg)
Number of subjects: 7
Study: 6754118

Group type: EXPERIMENTAL
Intervention: Oral erythromycin ethyl succinate (paediatric dosage)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Topical 1% tetracycline ointment
Number of subjects: 169
Study: 31801155

Group type: EXPERIMENTAL
Intervention: Heart rate characteristic (HRC) index 12 hours prior to diagnosis of UTI
Number of subjects: 2989

Group type: EXPERIMENTAL
Intervention: Heart rate characteristic (HRC) index 12 hours prior to diagnosis of BSI
Number of subjects: 2989

Group type: EXPERIMENTAL
Intervention: Baseline HRC index for meningitis
Number of subjects: 2989
Study: 30572905

Group type: EXPERIMENTAL
Intervention: Levofloxacin (15-20 mg/kg daily for six months)
Number of subjects: 1556

Group type: COMPARATOR
Intervention: Placebo (matching placebo for six months)
Number of subjects: 1556
Study: 27573335

Group type: EXPERIMENTAL
Intervention: Tablet computer with the Breathing Easier Support Toolkit (BEST)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Traditional method for teaching breathing techniques
Number of subjects: 71
Study: 24581407

Group type: EXPERIMENTAL
Intervention: Low-stretch compression bandaging
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High-stretch compression bandaging
Number of subjects: 8

Group type: COMPARATOR
Intervention: Baseline phase
Number of subjects: 8
Study: 22213304

Group type: EXPERIMENTAL
Intervention: Vinorelbine (oral) 60 mg/m² on days 1, 8, 15 every 4 weeks for 4 cycles (group A)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Paclitaxel (intravenous) 90 mg/m² for 1 h on days 1, 8, 15 every 4 weeks for a total of 4 cycles (group B)
Number of subjects: 74
Study: 20145555

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) training at 35 Hz for 5 minutes twice a week
Number of subjects: 0

Group type: COMPARATOR
Intervention: Isometric contraction stress (Control)
Number of subjects: 0
Study: 17384205

Group type: EXPERIMENTAL
Intervention: Vysis AutoVysion System
Number of subjects: 39
Study: 16088080

Group type: EXPERIMENTAL
Intervention: Eprosartan
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 12106923

Group type: EXPERIMENTAL
Intervention: LDL-A group (medication + LDL-A, n = 11)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Medication group (medication only, n = 7)
Number of subjects: 18
Study: 10579259

Group type: EXPERIMENTAL
Intervention: Helium:oxygen
Number of subjects: 19

Group type: COMPARATOR
Intervention: Air:oxygen
Number of subjects: 19
Study: 8907093

Group type: EXPERIMENTAL
Intervention: IA + SM + CT
Number of subjects: 48

Group type: COMPARATOR
Intervention: IA + SM + SC
Number of subjects: 48
Study: 1858944

Group type: EXPERIMENTAL
Intervention: Hypertonic saline infusion (0.855 M, 0.06 ml.min‐1.kg‐1)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Isotonic saline infusion (0.154 M, 0.06 ml.min‐1.kg‐1)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Hypertonic saline infusion (0.855 M)
Number of subjects: 7
Study: 6134885

Group type: EXPERIMENTAL
Intervention: Breast milk
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: High-protein cow's milk
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Adapted formula
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Low-protein cow's milk
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Soy-based formula
Number of subjects: 62